Amneal Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities
Amneal Pharmaceuticals, Inc.
2024
Description of Registrants Securities
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2020
Form of Tripartite Acknowledgment and Agreement Morgan Stanley
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Commitment Letter, dated as of October 17, 2017, among JPMorgan Chase Bank, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
PIPE Side Letter, dated November 21, 2017, by and among Amneal Holdings, LLC, Atlas Holdings, Inc., and TPG Improv Holdings, L.P
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Letter Agreement, dated as of June 26, 2015, between RBC Capital Markets LLC and Impax regarding the Additional Call Option Transaction
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Letter Agreement, dated as of June 26, 2015, between RBC Capital Markets LLC and Impax regarding the Additional Warrants
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Letter Agreement, dated as of June 25, 2015, between RBC Capital Markets LLC and Impax regarding the Base Call Option Transaction
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Letter Agreement, dated as of June 25, 2015, between RBC Capital Markets LLC and Impax regarding the Base Warrants
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Tax Receivable Agreement, among Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and the Members of Amneal Pharmaceuticals LLC from time to time party thereto
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Commitment Letter, dated as of October 17, 2017, among JPMorgan Chase Bank, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
PIPE Side Letter, dated November 21, 2017, by and among Amneal Holdings, LLC, Atlas Holdings, Inc., and TPG Improv Holdings, L.P
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018